Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6183990 | Gynecologic Oncology | 2008 | 8 Pages |
Abstract
DWI has potential to provide a surrogate biomarker of treatment response in advanced cervical cancers. The use of ADC offers an early and reproducible indication of tumour response which may ultimately allow the development of individualised regimens.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Vanessa N. Harry, Scott I. Semple, Fiona J. Gilbert, David E. Parkin,